Literature DB >> 17189218

Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population.

Rina Kimura1, Yoshihiro Kokubo, Kotaro Miyashita, Ryoichi Otsubo, Kazuyuki Nagatsuka, Toshiho Otsuki, Toshiyuki Sakata, Junko Nagura, Akira Okayama, Kazuo Minematsu, Hiroaki Naritomi, Shigenori Honda, Kiyoshi Sato, Hitonobu Tomoike, Toshiyuki Miyata.   

Abstract

gamma-Glutamyl carboxylation, a reaction essential for the activity of vitamin K-dependent proteins, requires the concerted actions of gamma-glutamyl carboxylase (GGCX), vitamin K 2, 3-epoxide reductase complex 1 (VKORC1), and the chaperone calumenin (CALU). We evaluated the contribution of genetic polymorphisms in VKORC1, GGCX, and CALU to interindividual variation in the activities of plasma protein C and protein S. We sequenced these 3 genes in 96 Japanese individuals and geno-typed 9 representative single-nucleotide polymorphisms in 3655 Japanese individuals representative of the general population. The mean activity of protein C in women bearing the GG genotype of GGCX 8016G>A (130.8% +/- 1.5%, n = 156) was significantly greater (P = .002) than that of individuals with either the AG (126.8% +/- 0.7%, n = 728) or the AA (125.4% +/- 0.6%, n = 881) genotype, after adjusting for confounding factors. The GGCX 8016G>A change leads to the substitution of Gin for Arg at amino acid residue 325 (Arg 325 Gln). This effect was comparable to that of a previously defined polymorphism in the protein C promoter. Mean protein S activity was influenced by the VKORC1 3730G>A and CALU 20943T>A genotypes, after adjusting for confounding factors. Thus, polymorphisms in genes involved in the vitamin K-dependent gamma-carboxylation reaction influence interindividual variation in the activities of protein C and protein S in the general population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189218     DOI: 10.1532/IJH97.06082

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  46 in total

1.  A quantitative trait locus influencing free plasma protein S levels on human chromosome 1q: results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) project.

Authors:  Laura Almasy; José Manuel Soria; Juan Carlos Souto; Imma Coll; Delphine Bacq; Alexandra Faure; José Mateo; Montserrat Borrell; Xavier Muñoz; Nuria Sala; William H Stone; Mark Lathrop; Jordi Fontcuberta; John Blangero
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-09       Impact factor: 8.311

2.  Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system.

Authors:  Nadeem Wajih; David C Sane; Susan M Hutson; Reidar Wallin
Journal:  J Biol Chem       Date:  2005-01-07       Impact factor: 5.157

3.  Population variation in VKORC1 haplotype structure.

Authors:  S Marsh; C R King; R M Porche-Sorbet; T J Scott-Horton; C S Eby
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

Review 4.  Molecular basis of vitamin K-dependent gamma-carboxylation.

Authors:  B Furie; B C Furie
Journal:  Blood       Date:  1990-05-01       Impact factor: 22.113

5.  Potential of carotid enlargement as a useful indicator affected by high blood pressure in a large general population of a Japanese city: the Suita study.

Authors:  T Mannami; S Baba; J Ogata
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

6.  VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation.

Authors:  Christof Geisen; Matthias Watzka; Katja Sittinger; Michael Steffens; Laurynas Daugela; Erhard Seifried; Clemens R Müller; Thomas F Wienker; Johannes Oldenburg
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

7.  Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans.

Authors:  Harumi Takahashi; Grant R Wilkinson; Edith A Nutescu; Takashi Morita; Marylyn D Ritchie; Maria G Scordo; Vittorio Pengo; Martina Barban; Roberto Padrini; Ichiro Ieiri; Kenji Otsubo; Toshitaka Kashima; Sosuke Kimura; Shinichi Kijima; Hirotoshi Echizen
Journal:  Pharmacogenet Genomics       Date:  2006-02       Impact factor: 2.089

8.  An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms.

Authors:  Chihiro Tanaka; Kei Kamide; Shin Takiuchi; Yoshikazu Miwa; Masayoshi Yoshii; Yuhei Kawano; Toshiyuki Miyata
Journal:  Hypertens Res       Date:  2003-04       Impact factor: 3.872

9.  A conserved region of human vitamin K-dependent carboxylase between residues 393 and 404 is important for its interaction with the glutamate substrate.

Authors:  Vasantha P Mutucumarana; Francine Acher; David L Straight; Da-Yun Jin; Darrel W Stafford
Journal:  J Biol Chem       Date:  2003-09-10       Impact factor: 5.157

10.  Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.

Authors:  Simone Rost; Andreas Fregin; Vytautas Ivaskevicius; Ernst Conzelmann; Konstanze Hörtnagel; Hans-Joachim Pelz; Knut Lappegard; Erhard Seifried; Inge Scharrer; Edward G D Tuddenham; Clemens R Müller; Tim M Strom; Johannes Oldenburg
Journal:  Nature       Date:  2004-02-05       Impact factor: 49.962

View more
  9 in total

1.  Delayed Vitamin K deficiency related bleeding: is it genetically linked?

Authors:  Tejasvita Gaikwad; Anshul Jadli; Kanjaksha Ghosh; Shrimati Shetty
Journal:  Indian J Pediatr       Date:  2013-09-14       Impact factor: 1.967

2.  Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum.

Authors:  Reiko Neki; Tomio Fujita; Koichi Kokame; Isao Nakanishi; Masako Waguri; Yuzo Imayoshi; Noriyuki Suehara; Tomoaki Ikeda; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2011-08-03       Impact factor: 2.490

Review 3.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

4.  A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.

Authors:  D Voora; D C Koboldt; C R King; P A Lenzini; C S Eby; R Porche-Sorbet; E Deych; M Crankshaw; P E Milligan; H L McLeod; S R Patel; L H Cavallari; P M Ridker; G R Grice; R D Miller; B F Gage
Journal:  Clin Pharmacol Ther       Date:  2010-03-03       Impact factor: 6.875

Review 5.  Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.

Authors:  Eric G Johnson; Benjamin D Horne; John F Carlquist; Jeffrey L Anderson
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

6.  Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.

Authors:  N A Limdi; H Wiener; J A Goldstein; R T Acton; T M Beasley
Journal:  Blood Cells Mol Dis       Date:  2009-03-17       Impact factor: 3.039

Review 7.  Warfarin pharmacogenetics.

Authors:  Nita A Limdi; David L Veenstra
Journal:  Pharmacotherapy       Date:  2008-09       Impact factor: 4.705

8.  Association of functional VKORC1 promoter polymorphism with occurrence and clinical aspects of ischemic stroke in a Greek population.

Authors:  Georgia Ragia; Stella Marousi; John Ellul; Vangelis G Manolopoulos; Anna Tavridou
Journal:  Dis Markers       Date:  2013-10-31       Impact factor: 3.434

9.  Relationship between VKORC1 single nucleotide polymorphism 1173C>T, bone mineral density & carotid intima-media thickness.

Authors:  Daniela Fodor; Cosmina Bondor; Adriana Albu; Radu Popp; Ioan Victor Pop; Laura Poanta
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.